Search

everythinglearnresearchcommunity

for

Search:↓

Water-soluble wool keratin can protect human hair from damage during treatments.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Hydroxychloroquine can help treat certain types of hair loss.

Dermoscopy greatly improves melanoma diagnosis and reduces unneeded surgeries.

Hair fibers may have a unique, non-protein sheath not previously identified.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

A rare EGFR mutation in newborns leads to severe health issues and early death.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

Betulin oil doesn't stop hair loss or help regrow hair in hypothyroidism.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Yale-New Haven Hospital won a top award for greatly improving asthma care and reducing related hospital visits and costs.

Histopathology is crucial for accurately diagnosing eruptive vellus hair cysts.

Steatocystoma multiplex is a skin condition starting around age 26, linked to hair follicles, and related to eruptive vellus hair cysts.

Perforating folliculitis is a skin condition with small bumps that may be linked to other diseases and is hard to treat.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Intralesional cidofovir might be a good alternative treatment.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Wnt signaling is vital for cell growth, development, and cancer research.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.